Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
macrogol 3350, Quantity: 6562.5 mg; sodium bicarbonate, Quantity: 89.25 mg; potassium chloride, Quantity: 23.3 mg; sodium chloride, Quantity: 175.35 mg
Arrotex Pharmaceuticals Pty Ltd
macrogol 3350,potassium chloride,sodium bicarbonate,sodium chloride
Powder, oral
Excipient Ingredients: acesulfame potassium
Oral
2,8,30
Not scheduled. Not considered by committee
For effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. For resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. For prevention of recurrence of faecal impaction in children aged 2 years and older. Use in children 2 years and older should be limited to 12 weeks except under medical supervision.
Visual Identification: A white to almost white fine powder in single-dose sachets.; Container Type: Sachet; Container Material: Al laminated with LDPE/paper; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-02-27